Menu

Interactive Infographic: State Laws for Medical Aid-in-Dying

In six states and the District of Columbia, terminally ill patients can get a perscription for a life-ending drug, and several additional states are considering legalizing the practice.

Aug 16, 2017
Catherine Offord

Medical aid-in-dying—a physician’s prescription for a lethal dose of a drug to end a patient’s life—is legal for terminally ill patients in six states and the District of Columbia. A further 30 states have been considering legislation on medical aid-in-dying during this year’s legislative session, according to advocacy group Death with Dignity. Euthanasia—the practice of assisting in someone else’s death directly, for example, by physician-administered lethal injection—is currently not legal anywhere in the United States. (Click the labeled states for more information about their practices.)

DEVELOPED BY KARL PAWLOWICZ

Since we developed this map, three additional states have proposed legislation regarding medical aid-in-dying: Oklahoma, New Jersey, and Rhode Island.

See world map for an overview of practices by country.

Correction (August 29): This map has been updated to correctly identify the light orange–shaded states as those considering legislation, while the medium orange states have no proposed legislation. The Scientist regrets the error.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.